News Focus
News Focus
icon url

stoneroad

02/23/12 4:57 PM

#75707 RE: mojojojo #75706

Bird in the hand......
icon url

Fire Fox

02/23/12 5:12 PM

#75709 RE: mojojojo #75706

Your question reminds me of SK's recent emphasis on the fact that there has been a very high level of consistency between pre-clinical / early clinical data, and the current results. For most biotech companies, there is no such consistency and the results of each trial are a crap shoot.

With the confidence the Company now has in the predictive value of their early data, I bet they wait for the unblinding before inking a Bavi deal.
icon url

jonnyrocket

02/23/12 5:15 PM

#75711 RE: mojojojo #75706

mojo - exciting times here....anxiously awaiting the 1st and 2nd Line data. Not sure what Steve and the BoD will do if they are seeing great data.
icon url

geocappy1

02/23/12 6:04 PM

#75715 RE: mojojojo #75706

If it si one indication for a region I think they need to make a deal. if it is a big partnering for a % of PPHm then they should wait.
icon url

freethemice

02/23/12 10:38 PM

#75723 RE: mojojojo #75706

mojo,
The question really is whether you believe the science will pay off, or not.
I am in this for the long-term, not the quick buck. I say wait it out.